MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis.
about
Tracking fetal development through molecular analysis of maternal biofluidsEmerging platforms using liquid biopsy to detect EGFR mutations in lung cancerCell-free fetal DNA in maternal plasma: an important advance to link fetal genetics to obstetric ultrasoundAlpha-thalassaemia and population health in Southeast Asia.MALDI-TOF mass spectrometry for quantitative, specific, and sensitive analysis of DNA and RNA.Recent developments in the detection of fetal single gene differences in maternal plasma and the role of size fractionation.Simple, efficient, and cost-effective multiplex genotyping with matrix assisted laser desorption/ionization time-of-flight mass spectrometry of hemoglobin beta gene mutations.MALDI-TOF MS in Prenatal Genomics.Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells.Reliable detection of paternal SNPs within deletion breakpoints for non-invasive prenatal exclusion of homozygous α-thalassemia in maternal plasma.Differential DNA methylation as a tool for noninvasive prenatal diagnosis (NIPD) of X chromosome aneuploidiesEfficient detection of Mediterranean β-thalassemia mutations by multiplex single-nucleotide primer extensionEpigenetic approaches for the detection of fetal DNA in maternal plasma.Restriction enzyme-mediated enhanced detection of circulating cell-free fetal DNA in maternal plasmaMass spectrometric based analysis, characterization and applications of circulating cell free DNA isolated from human body fluidsCell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation.Non-invasive prenatal diagnosis using fetal DNA in maternal plasma: a preliminary study for identification of paternally-inherited alleles using single nucleotide polymorphismsThe Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer.Non-invasive prenatal diagnosis using cell-free fetal nucleic acids in maternal plasma: Progress overview beyond predictive and personalized diagnosisNon-invasive prenatal diagnosis of aneuploidies: new technologies and clinical applications.Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers.Fetal DNA in maternal plasma: progress through epigenetics.Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma.10. Circulating Nucleic Acids as Diagnostic ToolPrenatal diagnosis: update on invasive versus noninvasive fetal diagnostic testing from maternal blood.Noninvasive prenatal diagnosis using ccffDNA in maternal blood: state of the art.Application of proteomics to prenatal screening and diagnosis for aneuploidies.Fetal DNA in maternal plasma: a noninvasive tool for prenatal diagnosis of beta-thalassemia.Noninvasive prenatal diagnosis of monogenic disorders.Non-invasive prenatal diagnostics using next generation sequencing: technical, legal and social challenges.Diagnosis and prevention of thalassemia.Cell-free Fetal Nucleic Acid Identifier Markers in Maternal Circulation.Non-invasive prenatal diagnosis of β-thalassemia by detection of the cell-free fetal DNA in maternal circulation: a systematic review and meta-analysis.Cell-free fetal nucleic acids as prenatal biomarkers.Prenatal diagnosis of fetal aneuploidies: post-genomic developments.No maternally inherited diabetes and deafness mutations in a sample of 193 Tasmanian diabetics with glaucoma.Noninvasive prenatal diagnosis experience in the Çukurova Region of Southern Turkey: detecting paternal mutations of sickle cell anemia and β-thalassemia in cell-free fetal DNA using high-resolution melting analysis.A new genotyping method for detecting low abundance single nucleotide mutations based on gap ligase chain reaction and quantitative PCR assay.Non-invasive prenatal testing for fetal inheritance of maternal β-thalassaemia mutations using targeted sequencing and relative mutation dosage: a feasibility study.Variability of ffDNA in maternal plasma does not prevent correct classification of trisomy 21 using MeDIP-qPCR methodology.
P2860
Q26995586-F9EA5005-61BD-4E1E-8542-129305D07C58Q28082499-051BCA53-7A33-4DD8-98BC-B0B76A00484DQ28241617-F6E3E2E3-ECDB-4279-A89C-37F6FF5A6E89Q33221593-32855AE7-1448-4BED-A6AC-1C778B0A4A0BQ33263722-8F6ABF26-251C-4825-A9CD-5D50F0A4CD0BQ33274418-FEF13DBE-B229-456D-9CB4-1F7F76B96304Q33450163-CC76D005-5CF9-4698-BA35-83726B054F3FQ33737845-6438BBC6-8628-4D37-B28D-128D8BB250B0Q33856619-B7C378E0-8930-44C3-932E-31BACB5CF970Q34042854-CE8412BC-499B-4CC2-9507-B4F457D2BA61Q34239768-8C05B0DD-7CE5-4E46-AB3D-BD4DFAAF8165Q34461027-5FCC7A46-774E-4C02-8B53-DBFC56DE37EEQ34558118-BCEB29F6-59E8-4C13-BD8E-8FBE45FD2CA1Q35069908-D12FF5B7-B365-4DA6-B703-6E17C3BF9760Q35099257-4799A452-E3D0-48A0-942F-B1E9F37514CAQ35434562-B08F9A07-7C2A-4D86-B5E7-57541BE3C2C6Q35885009-FB234E96-91A7-4F61-8275-531D62E850B4Q36095650-5CA009C0-91E0-488A-87ED-2FCCC2250ABDQ36117921-83A53BF1-9BB8-4619-8FF6-FB8A9E2DDEDBQ36424760-8072627C-27F4-4B89-B1C7-02108450B2AEQ36610034-F0F28058-BEBB-4F83-879B-FEBCDE1BC5A2Q36654711-3FAFA8AF-0C59-4351-9F73-2B11C1DA5AFEQ37000915-0CB53F4B-296E-4996-817A-424277DC13B6Q37155440-BAC8BE99-BCED-46DE-A947-7D8A55ECFC88Q37322448-8E7E09B1-11B2-463E-B9CD-990DAEF46BD9Q37705437-AB2542CD-3855-496C-81D2-865917BC5D44Q37801660-5A1B6262-52D5-4B03-8C78-BC59A6CE11B8Q38002921-A220E9C8-8D81-4847-AD1D-C9573A871FD3Q38002933-215CDCF9-4F8F-4937-AE5B-CA672C1EEC0BQ38088416-573B3EA1-1BF7-4D7E-AD6B-CCB0127631D9Q38167823-7CE72F54-DEC1-4F90-8674-E72C21046B89Q38371846-93A0A583-89F8-4342-A6BE-AC482FA8A394Q38770436-03855B30-AAA1-4479-97F6-84FE2A56D7DAQ39778751-3F5AC785-C308-44F3-8AC4-CA1C3FE652A8Q39850180-5B7E96C2-345D-4F65-B4D9-F99C24EAA371Q43951172-D07962B0-3124-480B-AA40-71A9CCDCB068Q44912114-ABDF82E2-5FB8-4498-93DA-8CF4EB465B6FQ45345399-FB4536BA-4F31-4C8C-8DE0-6C0B27900905Q50051267-D7370223-47A4-4E35-AC31-4EF03D31E343Q51039797-5AEB9B00-57D0-44AD-8883-EE79028CA36A
P2860
MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
MS analysis of single-nucleoti ...... oninvasive prenatal diagnosis.
@en
type
label
MS analysis of single-nucleoti ...... oninvasive prenatal diagnosis.
@en
prefLabel
MS analysis of single-nucleoti ...... oninvasive prenatal diagnosis.
@en
P2093
P2860
P50
P356
P1476
MS analysis of single-nucleoti ...... noninvasive prenatal diagnosis
@en
P2093
Amy Y Y Chan
Chanane Wanapirak
Charles R Cantor
Chunming Ding
Edmond S K Ma
Hai-Yang Law
Ivy S L Ng
Mary Anne Tan Jin Ai
P2860
P304
10762-10767
P356
10.1073/PNAS.0403962101
P407
P577
2004-07-09T00:00:00Z